Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.
Press releases published on September 30, 2025
Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.
VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs Inc. (OTC: FITY), a leader in AI-powered healthcare and biotechnology solutions, is excited to announce the signing of a Letter of Intent (LOI) to acquire BioSpark AI …
Acentra Health’s Dr. Ryan Bosch Named a 2025 Innovator in Health Care by Washington Business Journal
MCLEAN, Va., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company committed to accelerating better health outcomes for its clients and the populations they serve, today announced that its Chief Health …
MISTR & SISTR Launch First-Ever National PrEP Day to End HIV in America
Miami, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- MISTR, the nation’s largest telehealth platform for sexual health, and its companion platform SISTR, are launching the first-ever National PrEP Day on October 10, 2025. The groundbreaking campaign to launch the …
Parexel Announces AI Partnership with Weave Bio to Accelerate Regulatory Submission Processes
RALEIGH, N.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry today announced a partnership with Weave Bio, …
KPJ Healthcare Partners with NetSfere to Enhance Secure Communication Across 30 Hospitals
KUALA LUMPUR, Malaysia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- KPJ Healthcare Berhad (“KPJ Healthcare”), Malaysia’s largest private healthcare provider, has entered into a strategic partnership with NetSfere, a global provider of secure enterprise messaging …
Thousands of State of Georgia employees walk 880 million steps to benefit Title I schools
State Health Benefit Plan members come together to help young Georgians in their communities while improving their personal health ‘Jump Shot for Health’ awards winning schools new sports equipment and renovated basketball courts; initiative made possible …
Pharmaceutical Tariffs to Create More U.S. Jobs
Farmington Hills, MI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The landscape of global drug manufacturing is shifting rapidly as new U.S. tariffs on pharmaceuticals create powerful incentives to move production stateside. The move comes after President Trump …
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment About its Proprietary T-Cell Engager Program
Watch the "What This Means" video here Featuring Company’s second-generation T-Cell Engager program and advantages over first-generation Company’s T-Cell Engager program has made improvements in manufacturability, preclinical safety profile, and ability …
PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress
PETACH TIKVA, Israel, Sept. 30, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that Dr. Shmuel Sharoni will present the topline results …
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill children, a population with extremely limited treatment options Results highlight life-threatening gaps in pediatric care and …
24/7 Market News: Sportswear and Smart Textiles are likely Key Spider Silk Target Markets for Kraig Labs
DENVER, Sept. 30, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, highlights the opportunity for recombinant spider silk produced by Kraig Biocraft …
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer
New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, G12C, G13C, G12A, Q61H, and G13D mutations Company Reports first evidence of gastric cancer activity expands potential …
The MUHC Foundation’s Inaugural Breakthrough Run Wins Big at the Montreal Marathon
MONTREAL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The MUHC Foundation proudly hosted its inaugural Breakthrough Run at the Montreal Marathon, bringing together 22 teams and almost 200 dedicated runners, including health care professionals, grateful patients, …
La première édition de la Course vers la Percée de la Fondation du CUSM remporte un franc succès lors du Marathon de Montréal
MONTRÉAL, 30 sept. 2025 (GLOBE NEWSWIRE) -- La Fondation du CUSM est fière d’avoir organisé sa première Course vers la Percée lors du Marathon de Montréal. Cet événement a réuni 22 équipes et près de 200 coureurs engagés, dont des professionnels de la …
Global Companion Diagnostics Market to Surpass USD 13.6 Billion by 2029 | MarketsandMarkets™
Delray Beach, FL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global companion diagnostics market, valued at US$6.8 billion in 2023, stood at US$7.5 billion in 2024 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2029, culminating in a …
Vivex Biologics Treats First Patient in its Restore Trial Evaluating VIA Disc NP™ for Patients with Degenerative Disc Disease
MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S. clinical trial evaluating VIA Disc NP™ for patients with …
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
Disc is seeking accelerated approval and priority review of its NDA submission FDA decision to accept and file the NDA for review occurs within 60 days of submission WATERTOWN, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a …
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access
Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of …